| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1394.004 |
| P8608 | Fatcat ID | release_utduinfmnvbcnceiqe4mk3ofmi |
| P698 | PubMed publication ID | 17376839 |
| P50 | author | Karin E. Bornfeldt | Q87887672 |
| P2093 | author name string | Xia Shen | |
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice | Q24530027 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Genetic background determines response to hemostasis and thrombosis | Q33259449 | ||
| Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials | Q34112942 | ||
| Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice | Q34236802 | ||
| Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes | Q34372508 | ||
| Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options | Q34409474 | ||
| Advanced glycation end products: sparking the development of diabetic vascular injury | Q34555042 | ||
| Diabetic cardiomyopathy | Q34564427 | ||
| Rupture of the atherosclerotic plaque: does a good animal model exist? | Q35077352 | ||
| Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien | Q35088381 | ||
| Lipid overload and overflow: metabolic trauma and the metabolic syndrome | Q35568995 | ||
| Diabetes and hypertension: pathogenesis, prevention and treatment | Q36035797 | ||
| Tissue-specific hemostasis in mice | Q36241086 | ||
| Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus | Q36376535 | ||
| Role of changes in cardiac metabolism in development of diabetic cardiomyopathy | Q36496550 | ||
| Diabetic vascular disease: an experimental objective | Q36500921 | ||
| A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice | Q36606447 | ||
| Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis | Q37548758 | ||
| Diabetes as an atherogenic factor. | Q40176087 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Calmodulin-induced early-onset diabetes in transgenic mice | Q41840125 | ||
| Diabetic cardiomyopathy: fact or fiction? | Q43084189 | ||
| IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress | Q43618947 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Overexpression of metallothionein reduces diabetic cardiomyopathy. | Q43833575 | ||
| Carotid artery intima-media thickness in children with type 1 diabetes | Q43867572 | ||
| Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy | Q43935483 | ||
| Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice | Q43989979 | ||
| Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice | Q43996678 | ||
| RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. | Q44228474 | ||
| Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction | Q44505486 | ||
| Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes | Q44865527 | ||
| Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study | Q44895725 | ||
| Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. | Q45161321 | ||
| Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice | Q46508070 | ||
| Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy | Q46513290 | ||
| Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose | Q46745529 | ||
| Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes | Q46769986 | ||
| Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy | Q46966545 | ||
| Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. | Q53861995 | ||
| GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice | Q56093366 | ||
| STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells | Q56914451 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 202-217 | |
| P577 | publication date | 2007-03-21 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Mouse models for studies of cardiovascular complications of type 1 diabetes | |
| P478 | volume | 1103 |
| Q35415550 | Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process. |
| Q33565629 | Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits |
| Q34591282 | Animal models of cardiovascular diseases |
| Q39028912 | Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis |
| Q36479405 | Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities |
| Q57186141 | Diabetic cardiomyopathy |
| Q35777842 | Murine hyperglycemic vasculopathy and cardiomyopathy: whole-genome gene expression analysis predicts cellular targets and regulatory networks influenced by mannose binding lectin |
| Q90007917 | Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes |
| Q64087054 | Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease |
| Q36595067 | Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. |
Search more.